Pizzey's Hails FDA's Omega-3 Claim Approval
June 10, 2004 – Pizzey’s Milling (Angusville, Manitoba), North America’s leading specialty flaxseed ingredients supplier, welcomes the Food & Drug Administration’s (FDA) recent approval of nutrient content claims for alpha-linolenic acid (ALA) and other omega-3 oils. The approval became retroactive to January 16th, 2004 when the FDA declined to respond within the required 120-day time period to a petition submitted by the Washington firm of Olsson, Frank and Weeda, P.C. on behalf of three Washington-based Seafood processors. Consequently, the petition is considered “approved as written”, confirmed an FDA spokesperson. The approval was hailed by a broad range of parties, including the American Institute for Cancer Research (AICR) and the National Consumers League. The “Notification for a Nutrient Content Claim based on an Authoritative Statement” was premised upon authoritative statements made by the Institute of Medicine (IOM), a branch of the National Academy of Science.
The ruling not only confirms flaxseed’s status as a rich source of ALA omega-3s (Pizzey’s whole-milled flaxseed contains 20% by weight ALA omega-3), but also authorizes food manufacturers to make similar claims for products containing whole-milled flaxseed in their formulations.
“This is a very significant development for flaxseed as it codifies flaxseed’s unique potential to contribute significantly to nutritional health and well-being,” explains Linda Pizzey, President and co-founder of Pizzey’s Milling. “Now food manufacturers will be able to claim a nutritional advantage for their products on the basis of their products’ ALA-omega-3 contents.”
“This development is a major milestone in the long road that we have traveled to educate the public and the food and nutritional products industries on the unique nutritional benefits provided by flaxseed,” confirms Glenn Pizzey, Pizzey’s Milling co-founder and Executive Vice-President of Research & Operations. Glenn Pizzey has been a leading proponent for the funding for nutritional and medical research through organizations such as the Flax Council of Canada.
The new regulations recognize an Adequate Intake (AI) for ALA Omega-3 of 1.3-g per day for adults. Manufacturers will now be able to promote any products offering a minimum of 260-mg of ALA Omega-3 per serving as being “High-” or “Rich" in ALA-omega-3.